BioCentury
ARTICLE | Clinical News

VibeX riboflavin ophthalmic solution regulatory update

March 12, 2012 7:00 AM UTC

Avedro submitted an NDA to FDA for VibeX riboflavin ophthalmic solution for use with its KXL System for corneal cross-linking to treat keratoconus and corneal ectasia following refractive surgery. Vib...